scispace - formally typeset
R

Richard A. Flavell

Researcher at Yale University

Publications -  1389
Citations -  223064

Richard A. Flavell is an academic researcher from Yale University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 231, co-authored 1328 publications receiving 205119 citations. Previous affiliations of Richard A. Flavell include National Institute for Medical Research & University of Michigan.

Papers
More filters
Journal ArticleDOI

Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s).

TL;DR: These mutants will be useful for the study of IFN gamma regulation of class II genes and Ii chain, and to elucidate molecular components of type I and type II interferon signal transduction.
Journal ArticleDOI

Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

TL;DR: The data suggest that recombinant B. burgdorferi antigens can serve as substrates for immunoblot and ELISA, which may be helpful in diagnosing Lyme disease.
Journal ArticleDOI

AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites

TL;DR: It is found that knockin mice expressing an enzymatically inactive acidic mammalian chitinase (AMCase), the dominant true chitInase in mouse lung, showed enhanced type 2 immune responses to inhaled HDM, suggesting that AMCase is a crucial regulator of type 2immune responses to inhalation-containing aeroallergens.
Journal ArticleDOI

Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells.

TL;DR: It is found that MAVS, critical for the host RNA sensing pathway upstream of IFN induction, is degraded by the RV RNA methyl- and guanylyl-transferase (VP3) in a host-range-restricted manner and uncovered a novel pathogen-mediated inhibitory mechanism of MAVS signaling.